• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

合成、分子对接及含高碳醇和天然醇部分的 3-氧代-2- 甲苯基腙基-4,4,4-三氟丁酰基酯作为新型选择性羧酸酯酶抑制剂的研究

Synthesis, molecular docking, and biological evaluation of 3-oxo-2-tolylhydrazinylidene-4,4,4-trifluorobutanoates bearing higher and natural alcohol moieties as new selective carboxylesterase inhibitors.

机构信息

Institute of Physiologically Active Compounds Russian Academy of Sciences, Chernogolovka 142432, Russia.

Postovsky Institute of Organic Synthesis, Urals Branch of Russian Academy of Sciences, Yekaterinburg 620990, Russia.

出版信息

Bioorg Chem. 2019 Oct;91:103097. doi: 10.1016/j.bioorg.2019.103097. Epub 2019 Jul 3.

DOI:10.1016/j.bioorg.2019.103097
PMID:31323527
Abstract

To search for effective and selective inhibitors of carboxylesterase (CES), a series of 3-oxo-2-tolylhydrazinylidene-4,4,4-trifluorobutanoates bearing higher or natural alcohol moieties was synthesized via pre-transesterification of ethyl trifluoroacetylacetate with alcohols to isolate transesterificated oxoesters as lithium salts, which were then subjected to azo coupling with tolyldiazonium chloride. Inhibitory activity against porcine liver CES, along with two structurally related serine hydrolases, acetylcholinesterase and butyrylcholinesterase, were investigated using enzyme kinetics and molecular docking. Kinetics studies demonstrated that the tested keto-esters are reversible and selective mixed-type CES inhibitors. Analysis of X-ray crystallographic data together with our IR and NMR spectra and QM calculations indicated that the Z-isomers were the most stable. The kinetic data were well explained by the molecular docking results of the Z-isomers, which showed specific binding of the compounds in the CES catalytic active site with carbonyl oxygen atoms in the oxyanion hole and non-specific binding outside it. Some compounds were studied as inhibitors of the main human isozymes involved in biotransformation of ester-containing drugs, hCES1 and hCES2. Esters of geraniol (3d) and adamantol (3e) proved to be highly active and selective inhibitors of hCES2, inhibiting the enzyme in the nanomolar range, whereas esters of borneol (3f) and isoborneol (3g) were more active and selective against hCES1. Computational ADMET studies revealed that all test compounds had excellent intestinal absorption, medium blood-brain barrier permeability, and low hERG liability risks. Moreover, all test compounds possessed radical-scavenging properties and low acute toxicity. Overall, the results indicate that members of this novel series of esters have the potential to be good candidates as hCES1 or hCES2 inhibitors for biomedicinal applications.

摘要

为了寻找有效的、选择性的羧酸酯酶(CES)抑制剂,我们通过先将三氟乙酰乙酸乙酯与醇类物质进行预酯交换,以分离出作为锂盐的反式酯,然后再与甲苯重氮盐酸盐进行偶联反应,合成了一系列带有较高或天然醇部分的 3-氧代-2-(对甲苯基)腙基-4,4,4-三氟丁酸酯。采用酶动力学和分子对接法,研究了这些化合物对猪肝 CES 以及两种结构相关的丝氨酸水解酶(乙酰胆碱酯酶和丁酰胆碱酯酶)的抑制活性。动力学研究表明,所测试的酮酯是可逆的、选择性的混合类型 CES 抑制剂。X 射线晶体学数据分析以及我们的 IR 和 NMR 光谱和 QM 计算表明,Z-异构体是最稳定的。分子对接结果很好地解释了动力学数据,表明化合物在 CES 催化活性位点与氧阴离子空穴中的羰基氧原子特异性结合,而在其外部则是非特异性结合。一些化合物被研究为参与含酯药物生物转化的主要人类同工酶(hCES1 和 hCES2)的抑制剂。橙花醇(3d)和金刚烷醇(3e)的酯类被证明是 hCES2 的高效且选择性抑制剂,对该酶的抑制作用在纳摩尔范围内,而龙脑醇(3f)和异龙脑醇(3g)的酯类则对 hCES1 更具活性和选择性。计算的 ADMET 研究表明,所有测试化合物都具有良好的肠道吸收、中等的血脑屏障通透性和低 hERG 致心律失常风险。此外,所有测试化合物都具有自由基清除特性和低急性毒性。总的来说,这些结果表明,该系列酯类化合物具有成为用于生物医学应用的 hCES1 或 hCES2 抑制剂的潜力。

相似文献

1
Synthesis, molecular docking, and biological evaluation of 3-oxo-2-tolylhydrazinylidene-4,4,4-trifluorobutanoates bearing higher and natural alcohol moieties as new selective carboxylesterase inhibitors.合成、分子对接及含高碳醇和天然醇部分的 3-氧代-2- 甲苯基腙基-4,4,4-三氟丁酰基酯作为新型选择性羧酸酯酶抑制剂的研究
Bioorg Chem. 2019 Oct;91:103097. doi: 10.1016/j.bioorg.2019.103097. Epub 2019 Jul 3.
2
Synthesis of 2-arylhydrazinylidene-3-oxo-4,4,4-trifluorobutanoic acids as new selective carboxylesterase inhibitors and radical scavengers.合成 2-芳基腙基-3-氧代-4,4,4-三氟丁酸作为新型选择性羧酸酯酶抑制剂和自由基清除剂。
Bioorg Med Chem Lett. 2019 Dec 1;29(23):126716. doi: 10.1016/j.bmcl.2019.126716. Epub 2019 Oct 14.
3
Novel potent bifunctional carboxylesterase inhibitors based on a polyfluoroalkyl-2-imino-1,3-dione scaffold.基于多氟烷基-2-亚氨基-1,3-二酮骨架的新型强效双功能羧酸酯酶抑制剂。
Eur J Med Chem. 2021 Jun 5;218:113385. doi: 10.1016/j.ejmech.2021.113385. Epub 2021 Mar 15.
4
Synthesis, molecular docking, and biological activity of polyfluoroalkyl dihydroazolo[5,1-c][1,2,4]triazines as selective carboxylesterase inhibitors.多氟烷基二氢氮杂环并[5,1-c][1,2,4]三嗪作为选择性羧酸酯酶抑制剂的合成、分子对接及生物活性
Bioorg Med Chem. 2017 Aug 1;25(15):3997-4007. doi: 10.1016/j.bmc.2017.05.045. Epub 2017 May 20.
5
Synthesis, molecular docking and biological evaluation of N,N-disubstituted 2-aminothiazolines as a new class of butyrylcholinesterase and carboxylesterase inhibitors.新型丁酰胆碱酯酶和羧酸酯酶抑制剂N,N-二取代2-氨基噻唑啉的合成、分子对接及生物学评价
Bioorg Med Chem. 2016 Mar 1;24(5):1050-62. doi: 10.1016/j.bmc.2016.01.031. Epub 2016 Jan 18.
6
Discovery of natural alkaloids as potent and selective inhibitors against human carboxylesterase 2.发现天然生物碱作为有效和选择性的人羧酸酯酶 2 抑制剂。
Bioorg Chem. 2020 Dec;105:104367. doi: 10.1016/j.bioorg.2020.104367. Epub 2020 Oct 12.
7
hCES1 and hCES2 mediated activation of epalrestat-antioxidant mutual prodrugs: Unwinding the hydrolytic mechanism using in silico approaches.hCES1和hCES2介导的依帕司他-抗氧化剂互变异构前药的激活:利用计算机方法揭示水解机制
J Mol Graph Model. 2019 Sep;91:148-163. doi: 10.1016/j.jmgm.2019.06.012. Epub 2019 Jun 20.
8
Design, synthesis, and structure-activity relationship study of glycyrrhetinic acid derivatives as potent and selective inhibitors against human carboxylesterase 2.设计、合成及甘草次酸衍生物的构效关系研究作为高效和选择性抑制人羧酸酯酶 2 的抑制剂。
Eur J Med Chem. 2016 Apr 13;112:280-288. doi: 10.1016/j.ejmech.2016.02.020. Epub 2016 Feb 9.
9
A natural inhibitor from Alisma orientale against human carboxylesterase 2: Kinetics, circular dichroism spectroscopic analysis, and docking simulation.泽泻中一种天然的人羧酸酯酶 2 抑制剂:动力学、圆二色光谱分析及对接模拟。
Int J Biol Macromol. 2019 Jul 15;133:184-189. doi: 10.1016/j.ijbiomac.2019.04.099. Epub 2019 Apr 13.
10
Synthesis of new carboxylesterase inhibitors and evaluation of potency and water solubility.新型羧酸酯酶抑制剂的合成及其活性和水溶性评估。
Chem Res Toxicol. 2001 Dec;14(12):1563-72. doi: 10.1021/tx015508+.

引用本文的文献

1
Advances in isoxazole chemistry and their role in drug discovery.异恶唑化学的进展及其在药物发现中的作用。
RSC Adv. 2025 Mar 17;15(11):8213-8243. doi: 10.1039/d4ra08339c.
2
Combining Experimental and Computational Methods to Produce Conjugates of Anticholinesterase and Antioxidant Pharmacophores with Linker Chemistries Affecting Biological Activities Related to Treatment of Alzheimer's Disease.结合实验和计算方法,制备具有影响阿尔茨海默病治疗相关生物活性的连接化学结构的抗胆碱酯酶和抗氧化药效团缀合物。
Molecules. 2024 Jan 9;29(2):321. doi: 10.3390/molecules29020321.
3
analysis of selected nutrition rich fruit of Bunch berry () constituents as human acetylcholinesterase (hAchE), carbonic anhydrase II (hCA-II) and carboxylesterase 1 (hCES-1) inhibitory agents.
分析所选红果越桔富含营养的果实成分作为人乙酰胆碱酯酶(hAchE)、碳酸酐酶II(hCA-II)和羧酸酯酶1(hCES-1)抑制剂的情况。
Saudi J Biol Sci. 2023 Dec;30(12):103847. doi: 10.1016/j.sjbs.2023.103847. Epub 2023 Oct 20.
4
Derivatives of 9-phosphorylated acridine as butyrylcholinesterase inhibitors with antioxidant activity and the ability to inhibit β-amyloid self-aggregation: potential therapeutic agents for Alzheimer's disease.9-磷酸化吖啶衍生物作为具有抗氧化活性和抑制β-淀粉样蛋白自我聚集能力的丁酰胆碱酯酶抑制剂:阿尔茨海默病的潜在治疗药物。
Front Pharmacol. 2023 Aug 9;14:1219980. doi: 10.3389/fphar.2023.1219980. eCollection 2023.
5
Conjugates of Tacrine and Salicylic Acid Derivatives as New Promising Multitarget Agents for Alzheimer's Disease.他克林和水杨酸衍生物的缀合物作为阿尔茨海默病的新型有希望的多靶标药物。
Int J Mol Sci. 2023 Jan 24;24(3):2285. doi: 10.3390/ijms24032285.
6
Powerful Potential of Polyfluoroalkyl-Containing 4-Arylhydrazinylidenepyrazol-3-ones for Pharmaceuticals.含多氟烷基的 4-芳基腙基吡唑-3-酮在药物方面的巨大潜力。
Molecules. 2022 Dec 21;28(1):59. doi: 10.3390/molecules28010059.
7
Synthesis of 4-Aminopyrazol-5-ols as Edaravone Analogs and Their Antioxidant Activity.4-氨基吡唑-5-醇的合成及其作为依达拉奉类似物的抗氧化活性。
Molecules. 2022 Nov 9;27(22):7722. doi: 10.3390/molecules27227722.
8
New Multifunctional Agents for Potential Alzheimer's Disease Treatment Based on Tacrine Conjugates with 2-Arylhydrazinylidene-1,3-Diketones.基于与 2-芳基腙-1,3-二酮的他克林缀合物的新型多功能阿尔茨海默病治疗潜在药物。
Biomolecules. 2022 Oct 24;12(11):1551. doi: 10.3390/biom12111551.
9
1-(3--Butylphenyl)-2,2,2-Trifluoroethanone as a Potent Transition-State Analogue Slow-Binding Inhibitor of Human Acetylcholinesterase: Kinetic, MD and QM/MM Studies.1-(3--丁基苯基)-2,2,2-三氟乙酮作为人乙酰胆碱酯酶的强效过渡态类似物缓慢结合抑制剂:动力学、MD 和 QM/MM 研究。
Biomolecules. 2020 Nov 27;10(12):1608. doi: 10.3390/biom10121608.
10
Monoterpenes and Their Derivatives-Recent Development in Biological and Medical Applications.单萜及其衍生物——生物医学应用的最新进展。
Int J Mol Sci. 2020 Sep 25;21(19):7078. doi: 10.3390/ijms21197078.